|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.9 TWD | +0.85% |
|
+1.13% | +8.48% |
Allied Biotech Corporation reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 379.35 million compared to TWD 359.77 million a year ago. Net income was TWD 60.14 million compared to TWD 63.09 million a year ago.
Basic earnings per share from continuing operations was TWD 0.63 compared to TWD 0.66 a year ago. Diluted earnings per share from continuing operations was TWD 0.63 compared to TWD 0.66 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +8.48% | 52.56M | |
| +8.20% | 7.78B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -13.13% | 3.44B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M | |
| -16.45% | 802M |
ALLIED BIOTECH CORPORATION 
